Status:
COMPLETED
Effectiveness of Vibrating Mesh Versus Small Volume Nebuliser in Chronic Obstructive Pulmonary Disease (COPD)
Lead Sponsor:
Beaumont Hospital
Collaborating Sponsors:
Aerogen
Conditions:
Chronic Obstructive Pulmonary Disease
COPD
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
When patients get an attack of COPD, one of the main treatments is regular nebulised medications called bronchodilators. These medications act by opening up the airways allowing patients to breathe ea...
Detailed Description
COPD is a common chronic respiratory disease. It is characterised by repeated episodes of acute worsening of symptoms of cough, wheeze and breathlessness called exacerbations. Exacerbations result in ...
Eligibility Criteria
Inclusion
- Admission with acute exacerbation of COPD within 24 hours of presentation to hospital
- Age \>40
- Confirmed COPD diagnosis (FEV1/FVC \<0.70 on spirometry)
- Willing to participate in the study and provide informed consent
Exclusion
- Admission for reason other than COPD exacerbation e.g. Heart Failure
- Acute confusion as per clinical team
- Allergy or contraindication to combined bronchodilator medication
- Severe respiratory sepsis as evident by temperature \>38 degrees and/or lobar pneumonia on Chest Radiograph
- Sustained tachycardia \>120bpm
- Patients with very advanced COPD, admitted for palliative or long term care
- Patients re-admitted within 90 days who have already been enrolled in the study.
Key Trial Info
Start Date :
October 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2018
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT03286855
Start Date
October 18 2017
End Date
September 30 2018
Last Update
July 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beaumont Hospital
Dublin, Ireland